Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$486.62 USD
+1.86 (0.38%)
Updated Oct 2, 2024 04:00 PM ET
Pre-Market: $482.00 -4.62 (-0.95%) 9:24 AM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$486.62 USD
+1.86 (0.38%)
Updated Oct 2, 2024 04:00 PM ET
Pre-Market: $482.00 -4.62 (-0.95%) 9:24 AM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
QIAGEN (QGEN) Misses Q2 Earnings Estimates, Lowers View
by Zacks Equity Research
QIAGEN (QGEN) registers revenue growth across majority of its geographies in Q2.
PerkinElmer (PKI) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Higher revenues and growth in Diagnostics segment benefit PerkinElmer's (PKI) Q2 earnings. However, forex remains a woe.
Ecolab (ECL) Q2 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Ecolab (ECL) gains from solid segmental contributions in the second quarter. It retains 2019 EPS view.
Will Intuitive Surgical (ISRG) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Intuitive Surgical (ISRG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Intuitive Surgical (ISRG) Q2 Earnings Beat, Guidance Narrowed
by Zacks Equity Research
Intuitive Surgical (ISRG) expects 2019 procedure growth within 16-17%.
Should You Buy Intuitive Surgical (ISRG) Ahead of Earnings?
by Zacks Equity Research
Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The 5 Hottest Earnings Charts This Week
by Tracey Ryniec
The 5 stocks have had the sizzle over the last 5 years. Will it continue this week?
Intuitive Surgical to Boost da Vinci Platform With Buyout
by Zacks Equity Research
Intuitive Surgical's (ISRG) acquisition of Scholly Fiberoptic's robotic endoscope business to likely boost the acquirer's da Vinci Surgical system.
Intuitive Surgical (ISRG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Intuitive Surgical (ISRG) closed the most recent trading day at $526.25, moving -1.82% from the previous trading session.
Can Instruments Drive Intuitive Surgical (ISRG) Q2 Earnings?
by Zacks Equity Research
Intuitive Surgical (ISRG) expects its core Instruments and Accessories unit to boost second-quarter 2019 results.
Tap AI-Powered Medical Device Stocks as FDA Bolsters SaMD
by Urmimala Biswas
The whole MedTech community finds a reason to cheer over with the FDA's recent proposal for Software as a Medical Device.
Intuitive Surgical (ISRG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Intuitive Surgical (ISRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medical Products Industry Outlook: Growth Prospects Radiant
by Trina Mukherjee
Growth prospects look bright for the Zacks Medical Products industry, thanks to AI, Medical Mechatronics and Robotics and rampant M&As.
Intuitive Surgical (ISRG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Intuitive Surgical (ISRG) closed at $477.22, marking a +1.12% move from the previous day.
Intuitive Surgical (ISRG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Intuitive Surgical (ISRG) closed at $476.13, marking a +0.49% move from the previous day.
Intuitive Surgical (ISRG) Down 7.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Market Edge Highlights: UFO, FINX, FIVE and ISRG
by Zacks Equity Research
Zacks Market Edge Highlights: UFO, FINX, FIVE and ISRG
Where to Find Great Investment Ideas
by Tracey Ryniec
Looking for some new stock and ETF ideas? Tracey and Neena share their secret sources.
Varian's (VAR) Halcyon to Treat Patients at Japan's Hospital
by Zacks Equity Research
Varian's (VAR) Halcyon sees encouraging developments in recent times.
Top Analyst Reports for Celgene, Schlumberger & Becton, Dickinson
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Celgene (CELG), Schlumberger (SLB) and Becton, Dickinson (BDX).
3 Medical Product Stocks Set to Beat This Earnings Season
by Urmimala Biswas
The global medical device space takes significant strides in terms of research and development (R&D) and regulatory progress in the first quarter.
Intuitive Surgical (ISRG) Q1 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Intuitive Surgical's (ISRG) Q1 results outside the United States impress.
5 Spectacular Large Cap Earnings Charts
by Tracey Ryniec
Which large cap earnings reports should you be watching this week?
Here's Why You Should Invest in Robotics ETFs
by Neena Mishra
Robotics, AI and automation are transforming our lives. Here's what investors need to know.
Will Instruments Drive Intuitive Surgical (ISRG) Q1 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) Systems and Services revenues are likely to boost Q1 results.